MEVALONATE PATHWAY INHIBITION BY STATINS POTENTIATES THE ANTITUMOR ACTIVITY OF ADAGRASIB IN KRASG12C-MUTANT LUNG CANCER CELLS (EORTC-NCI-AACR 2026) - Sep 11, 2026 - Abstract #287; PB-079; Pres time: Nov 20, 2026; Location: Exhibition Hall; "Abstract will be available as of 4 November (with consent of the author)"
Lung Cancer • Oncology • Solid Tumor • KRAS
|